As of 2025-09-18, the Intrinsic Value of Cerevel Therapeutics Holdings Inc (CERE) is -12.64 USD. This CERE valuation is based on the model Peter Lynch Fair Value. With the current market price of 44.96 USD, the upside of Cerevel Therapeutics Holdings Inc is -128.11%.
Based on its market price of 44.96 USD and our intrinsic valuation, Cerevel Therapeutics Holdings Inc (CERE) is overvalued by 128.11%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -12.64 - -12.64 | -12.64 | -128.11% |
| P/E | (38.92) - (30.78) | (35.38) | -178.7% |
| DDM - Stable | (24.13) - (78.00) | (51.06) | -213.6% |
| DDM - Multi | (1.39) - (3.45) | (1.97) | -104.4% |
| Market Cap (mil) | 8,191.26 |
| Beta | 1.22 |
| Outstanding shares (mil) | 182.19 |
| Enterprise Value (mil) | 8,208.75 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.12% |
| Cost of Debt | 5.00% |
| WACC | 8.96% |